Nathan Ford

8.9k total citations · 1 hit paper
117 papers, 5.4k citations indexed

About

Nathan Ford is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Nathan Ford has authored 117 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Infectious Diseases, 49 papers in Epidemiology and 32 papers in Virology. Recurrent topics in Nathan Ford's work include HIV/AIDS Research and Interventions (71 papers), HIV/AIDS drug development and treatment (33 papers) and HIV Research and Treatment (32 papers). Nathan Ford is often cited by papers focused on HIV/AIDS Research and Interventions (71 papers), HIV/AIDS drug development and treatment (33 papers) and HIV Research and Treatment (32 papers). Nathan Ford collaborates with scholars based in Switzerland, South Africa and United Kingdom. Nathan Ford's co-authors include Edward J. Mills, Graham Cooke, Helen Cox, Zara Shubber, Alexandra Calmy, Marco Vitória, Andrew Boulle, Katharina Kranzer, Meg Doherty and Lynne Mofenson and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Nathan Ford

112 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impact of climate change and natural disasters on fungal infections

2024 83 citations Danila Seidel, Sebastian Wurster et al. The Lancet Microbe profile →

Peers

Countries citing papers authored by Nathan Ford

Since Specialization

Citations

This map shows the geographic impact of Nathan Ford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Ford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Ford more than expected).

Fields of papers citing papers by Nathan Ford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan Ford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Ford. The network helps show where Nathan Ford may publish in the future.

Co-authorship network of co-authors of Nathan Ford

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan Ford. A scholar is included among the top collaborators of Nathan Ford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan Ford. Nathan Ford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Diagnostic accuracy of the WHO clinical staging system for detection of immunologically defined advanced HIV disease: A systematic review and meta‐analysis 2025 ·HIV Medicine ·(unknown), Akitoshi Ueno, (unknown), Ross Murtagh, (unknown), Seyed Alireza Mortazavi, David S. Lawrence, Augustine Choko, (unknown), Kelvin Balakasi, Ajay Rangaraj, Nathan Ford, Joseph N Jarvis, Peter MacPherson	0
2	Impact of climate change and natural disasters on fungal infections breakdown → 2024 ·The Lancet Microbe ·Danila Seidel, Sebastian Wurster, Jeffrey D. Jenks, Hatim Sati, Jean‐Pierre Gangneux, Matthias Egger, Ana Alastruey‐Izquierdo, Nathan Ford, Anuradha Chowdhary, Rosanne Sprute, Oliver A. Cornely, George R. Thompson, Martin Hoenigl, Dimitrios P. Kontoyiannis	83
3	The role and challenges of cluster randomised trials for global health 2021 ·The Lancet Global Health ·Louis Dron, Monica Taljaard, Yin Bun Cheung, Rebecca F. Grais, Nathan Ford, Kristian Thorlund, Fyezah Jehan, Etheldreda Nakimuli‐Mpungu, Denis Xavier, Zulfiqar A Bhutta, Jay Park, Edward J. Mills	39
4	Population‐wide differentials in HIV service access and outcomes in the Western Cape for men as compared to women, South Africa: 2008 to 2018: a cohort analysis 2020 ·Journal of the International AIDS Society ·Meg Osler, Morna Cornell, Nathan Ford, Katherine Hilderbrand, Eric Goemaere, Andrew Boulle	31
5	Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects 2019 ·Journal of the International AIDS Society ·Lynne Mofenson, Anton Pozniak, (unknown), Elliot Raizes, Andrea Ciaranello, Polly Clayden, Peter Ehrenkranz, Ade Fakoya, Andrew Hill, Saye Khoo, Imelda Mahaka, Surbhi Modi, Cynthia A. Moore, Andrew Phillips, George K. Siberry, (unknown), Claire Thorne, Heather Watts, Meg Doherty, Nathan Ford	30
6	Adherence to HIV post-exposure prophylaxis for children/adolescents who have been sexually assaulted: A systematic review of barriers, enablers, and interventions 2019 ·Child Abuse & Neglect ·Zara Shubber, Nathan Ford	8
7	HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries 2018 ·PLoS Medicine ·Olga Tymejczyk, Ellen Brazier, Constantin T. Yiannoutsos, Kara Wools‐Kaloustian, Keri N. Althoff, Brenda Crabtree‐Ramírez, Kinh Van Nguyen, Elizabeth Zaniewski, François Dabis, Jean d’Amour Sinayobye, Nanina Anderegg, Nathan Ford, (unknown), Denis Nash	28
8	Use of peers to improve adherence to antiretroviral therapy: a global network meta‐analysis 2016 ·Journal of the International AIDS Society ·Steve Kanters, Jay Park, Keith C. Chan, Nathan Ford, Jamie I. Forrest, Kristian Thorlund, Jean B. Nachega, Edward J. Mills	30
9	Risk factors for mortality during antiretroviral therapy in older populations in resource‐limited settings 2016 ·Journal of the International AIDS Society ·D. O’Brien, Tim Spelman, Jane Greig, James McMahon, (unknown), Esther C. Casas, (unknown), Philipp du Cros, Nathan Ford	10
10	Sensitivity and specificity of dried blood spots for HIV-1 viral load quantification 2016 ·Medicine ·Pieter Pannus, (unknown), (unknown), Nathan Ford, Katrien Fransen	23
11	Reducing CD4 Monitoring in Children on Antiretroviral Therapy With Virologic Suppression 2015 ·The Pediatric Infectious Disease Journal ·Mary‐Ann Davies, Nathan Ford, Helena Rabie, Geoffrey Fatti, Kathryn Stinson, Janet Giddy, Frank Tanser, Karl‐Günter Technau, Shobna Sawry, Brian Eley, Robin Wood, Lynne Mofenson, Olivia Keiser, Andrew Boulle	8
12	Formulating the Future Research Agenda for Postexposure Prophylaxis for HIV: Methodological Challenges and Potential Approaches 2015 ·Clinical Infectious Diseases ·Nandi Siegfried, Rachel Beanland, Nathan Ford, Kenneth H. Mayer	17
13	The scourge of tuberculosis and anti-tuberculosis drug resistance in Eastern Europe 2014 ·Public Health Action ·Helen Cox, Nathan Ford	3
14	Decentralisation of multidrug-resistant-tuberculosis care and management 2013 ·The Lancet Infectious Diseases ·Helen Cox, Nathan Ford	10
15	Outcomes of clofazimine for the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis 2012 ·Journal of Antimicrobial Chemotherapy ·(unknown), Grania Brigden, Helen Cox, Zara Shubber, Graham Cooke, Nathan Ford	100
16	Caring for Children with Drug-Resistant Tuberculosis: Practice-based Recommendations 2012 ·American Journal of Respiratory and Critical Care Medicine ·James A. Seddon, Jennifer Furin, Marianne Gale, (unknown), Rocio Hurtado, Farhana Amanullah, Nathan Ford, Jeffrey R. Starke, H. Simon Schaaf	50
17	Adherence to HIV post-exposure prophylaxis in victims of sexual assault: a systematic review and meta-analysis 2012 ·Sexually Transmitted Infections ·Liza Chacko, Nathan Ford, (unknown), Ruby Siddiqui	53
18	Unstructured treatment interruption of antiretroviral therapy in clinical practice: a systematic review 2011 ·Tropical Medicine & International Health ·Katharina Kranzer, Nathan Ford	111
19	Safety of task-shifting for male medical circumcision 2011 ·AIDS ·Nathan Ford, Kathryn Chu, Edward J. Mills	49
20	Registration problems for antiretrovirals in Africa 2006 ·The Lancet ·Nathan Ford, Marta Darder	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact